id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2334-0006,FDA,FDA-2020-E-2334,Determination of Regulatory Review Period for Purposes of Patent Extension; ROZLYTREK INJECTION; Correction,Notice,Correction,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,,2023-11-17T21:09:11Z,2023-25489,0,0,090000648628d12a